References
- Shaw AT, Solomon B. Targeting anaplastic lymphoma kinase in lung cancer. Clin Cancer Res. 2011;17(8):2081–2086.
- Takahashi T, Sonobe M, Kobayashi M, et al. Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene. Ann Surg Oncol. 2010;17(3):889–897.
- Perner S, Wagner PL, Demichelis F, et al. EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia. 2008;10(3):298–302.
- Boland JM, Erdogan S, Vasmatzis G, et al. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Hum Pathol. 2009;40(8):1152–1158.
- Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009;27(26):4247–4253.
- Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–566.
- Wong DW, Leung EL, So KK, et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer. 2009;115(8):1723–1733.
- Solomon B, Varella-Garcia M, Camidge DR. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol. 2009;4(12):1450–1454.
- Lindeman NI, Cagle PT, Beasley MB, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med. 2013;137(6):828–860.
- Moran T, Sequist LV. Timing of epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung cancer with EGFR mutations. J Clin Oncol. 2012;30(27):3330–3336.
- Pavlidis N. Lung cancer during pregnancy: an emerging issue. Lung Cancer. 2008;59(3):279–281.
- Rothschild SI. Lung cancer in pregnancy – a forgotten disease entity. J Thorac Oncol. 2016;11(9):1376–1378.
- mdanderson.org. Internet. The University of Texas M D Anderson Cancer Center. 2017; [cited 2017 Apr 25]. Available from: https://www.mdanderson.org/documents/for-physicians/algorithms/cancer-treatment/ca-treatment-non-small-cell-web-algorithm.pdf
- Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279–287.
- Mitrou S, Petrakis D, Fotopoulos G, et al. Lung cancer during pregnancy: a narrative review. J Adv Res. 2016;7(4):571–574.
- Kerjouan M, Jouneau S, Corre R, et al. Diagnosis and management of lung cancer during pregnancy. Rev Mal Respir. 2013;30(2):125–136.